diff --git a/assets/2022-Gandasegui-etal-Ivermectin-and-albendazole-co-administration_1730288717118_0.pdf b/assets/2022-Gandasegui-etal-Ivermectin-and-albendazole-co-administration_1730288717118_0.pdf
new file mode 100644
index 00000000..790d7d43
Binary files /dev/null and b/assets/2022-Gandasegui-etal-Ivermectin-and-albendazole-co-administration_1730288717118_0.pdf differ
diff --git a/journals/2024_10_28.md b/journals/2024_10_28.md
index 9987983a..336ad6ec 100644
--- a/journals/2024_10_28.md
+++ b/journals/2024_10_28.md
@@ -60,6 +60,7 @@
 		- REALISE protocol ![REALISE_protocol-PACTR.pdf](../assets/REALISE_protocol-PACTR_1730287576652_0.pdf) https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=27219
 		- Fixed-dose IVM metaanalysis ![24-11-ASTMH-fdivm-Echazu_etal_QR.pdf](../assets/24-11-ASTMH-fdivm-Echazu_etal_QR_1730288361632_0.pdf)
 		- ALIVE protocol ![2022-An-adaptive-phase-ii-iii-safety-and.pdf](../assets/2022-An-adaptive-phase-ii-iii-safety-and_1730288434715_0.pdf)
+		- Gandasegui et al. ![2022-Gandasegui-etal-Ivermectin-and-albendazole-co-administration.pdf](../assets/2022-Gandasegui-etal-Ivermectin-and-albendazole-co-administration_1730288717118_0.pdf)
 		-
 	- TODO [#A] RESPONDER a Sietepar con los comentarios de texto para la Landing 
 	  SCHEDULED: <2024-10-30 Wed>